Dietary regulation of the hepatic epigenome

肝脏表观基因组的饮食调节

• 批准号: 10434846
• 负责人: JOHN M DENU
• 金额: $ 58.27万
• 依托单位: UNIVERSITY OF WISCONSIN-MADISON
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-07-01 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10434846
• 关键词: Address; Adult; Affect; Alzheimer' s Disease; American; Amino Acids; Animals; Attention; Biological; Branched-Chain Amino Acids; Caloric Restriction; Calories; Cardiovascular Diseases; Cell Culture Techniques; Cells; Chemicals; Chromatin; Chromatin Structure; Complex; Complications of Diabetes Mellitus; Consumption; Development; Diabetes Mellitus; Diet; Dietary Component; Dietary Intervention; Disease; Eating; Energy Intake; Enzymes; Epigenetic Process; Essential Amino Acids; Evolution; FRAP1 gene; Fasting; Genetic Transcription; Goals; Health; Health Benefit; Hepatic; Heterochromatin; Histones; Human; In Vitro; Individual; Insulin Resistance; Intake; Intervention; Isoleucine; Knowledge; Laboratories; Leucine; Link; Long-Term Effects; Longevity; Macronutrients Nutrition; Maintenance; Malignant Neoplasms; Mediating; Metabolic; Metabolic Control; Metabolic syndrome; Metabolism; Methionine; Methylation; Modification; Molecular; Mus; Non-Insulin-Dependent Diabetes Mellitus; Obesity; Obesity Epidemic; Outcome; Overweight; Pathway interactions; Persons; Pharmacological Treatment; Pharmacology; Phosphotransferases; Physiological; Prevalence; Proteins; Regimen; Regulation; Risk; Rodent; Role; S-Adenosylmethionine; Thinness; United States; Valine; Vegan Diet; Work; base; detection of nutrient; diabetes risk; diet-induced obesity; dietary; dietary restriction; disorder risk; epigenetic memory; epigenome; experimental study; feeding; glycemic control; histone methylation; histone methyltransferase; improved; in vivo; insulin sensitivity; laboratory experiment; metabolome; novel strategies; obesity prevention; obesity treatment; post SARS-CoV-2 infection; preservation; prevent; protective effect; response; sensor; targeted treatment; transcriptome

Obesity is linked with an increased risk of diseases that include type 2 diabetes, cardiovascular disease, cancer, Alzheimer’s disease, and now emerging evidence indicates that obesity and diabetes are linked with worse outcomes following COVID-19 infection, even in the young. Type 2 diabetes affects over 29 million Americans, and the prevalence of diabetes, primarily driven by the obesity epidemic, continues to rise. Dietary interventions to control or prevent type 2 diabetes could be highly effective and affordable, but reduced calorie diets have proven to be unsustainable over the long term. New approaches to maintain metabolic health are therefore urgently needed. We and others have begun to investigate the role of specific dietary amino acids in the control of metabolic health, finding that in mice restriction of essential dietary amino acids, including methionine and the branched-chain amino acids (BCAAs; leucine, isoleucine and valine) can promote metabolic health and even reverse diet-induced obesity and insulin resistance. Understanding the physiological and molecular mechanisms by which restriction of calories or specific amino acids promotes metabolic health will permit the development of new pharmacological approaches to treat and prevent obesity and diabetes. Here, we will examine how dietary restriction of each of the nine essential amino acids alters the hepatic epigenome, metabolome, and transcriptome. We will examine the reversibility of methionine depletion (MD)- induced changes, and determine if MD alters the epigenome through depletion of epi-metabolites or by altering the activity of AA-responsive kinases. We will conduct in vitro and cell culture experiments to highlight the precise molecular pathways engaged by MD. Finally, we will investigate the contributions of reduced calorie intake and prolonged daily fasting, which calorie restricted (CR) animals are typically subjected to in most laboratory experiments, to the effects of a CR diet on the epigenome (chromatin structure, chemical modifications and gene transcription states) through altered metabolism. The proposed work will address long-standing questions regarding the molecular mechanisms by which dietary components regulate metabolic health. In terms of translatability, this work will enable our laboratories to develop a mechanistic understanding of how when, how much, and what we eat regulates health and disease vulnerability, and to identify new targets for the pharmacological treatment of obesity and diabetes.

肥胖与患2型糖尿病、心血管疾病、癌症、阿尔茨海默氏症等疾病的风险增加有关，现在越来越多的证据表明，肥胖和糖尿病与新冠肺炎感染后更糟糕的结局有关，即使在年轻人中也是如此。2型糖尿病影响着2900多万美国人，糖尿病的患病率，主要是由肥胖症流行推动的，继续上升。控制或预防2型糖尿病的饮食干预可能是非常有效和负担得起的，但从长远来看，减少卡路里饮食已被证明是不可持续的。因此，迫切需要新的方法来维持新陈代谢健康。我们和其他人已经开始研究特定饮食氨基酸在控制代谢健康中的作用，发现在小鼠中限制必需的饮食氨基酸，包括蛋氨酸和支链氨基酸(BCAA；亮氨酸、异亮氨酸和缬氨酸)可以促进代谢健康，甚至逆转饮食诱导的肥胖和胰岛素抵抗。了解限制卡路里或特定氨基酸促进代谢健康的生理和分子机制将有助于开发治疗和预防肥胖症和糖尿病的新的药理学方法。在这里，我们将研究饮食限制如何改变肝脏的表观基因组、代谢组和转录组。我们将研究蛋氨酸耗竭(MD)引起的改变的可逆性，并确定MD是否通过耗尽表观代谢物或改变AA反应激酶的活性来改变表观基因组。我们将进行体外和细胞培养实验，以突出MD参与的确切分子途径。最后，我们将研究减少卡路里摄入量和延长每日禁食时间，这是卡路里限制(CR)动物在大多数实验室实验中通常受到的影响，对CR饮食通过改变代谢对表观基因组(染色质结构、化学修饰和基因转录状态)的影响的贡献。这项拟议的工作将解决长期存在的关于饮食成分调节代谢健康的分子机制的问题。在可译性方面，这项工作将使我们的实验室能够机械地理解我们何时、吃多少以及吃什么来调节健康和疾病的脆弱性，并为肥胖症和糖尿病的药物治疗确定新的靶点。